UMS AG reports on first nine months of 2013

Hamburg, November 11, 2013 – UMS United Medical Systems International AG (UMS/ ISIN DE0005493654) has presented its figures for the first nine months of 2013. The Company’s third-quarter earnings were satisfactory, particularly considering recent changes in the USD/EUR exchange rate, which are unfavorable to UMS. Net income came in at EUR 2.4 million, which was at the previous year’s level. Earnings per share were the same as a year earlier at 13 cents. Consolidated sales under IFRS were EUR 9.8 million in the third quarter of 2013, following EUR 10.3 million in the prior year period. Adjusted for exchange rate effects, total sales were EUR 10.1 million, which is a slight decrease of 2% compared to last year.

In the first nine months of the 2013 fiscal year, UMS had consolidated sales of EUR 29.9 million, against EUR 31.9 a year ago. Gross profit decreased from EUR 15.8 million last year to EUR 14.5 million this year. EBITDA in the first three quarters of 2013 came to EUR 11.6 million, compared with EUR 12.8 in the same period a year ago. EBIT was EUR 8.8 million, versus EUR 9.6 million in 2012. Net income was EUR 7.4 million in the first nine months of 2013, following EUR 8.0 million a year ago. UMS’s earnings per share came to 37 cents in the nine month period, compared with 43 cents in the same period last year.

UMS remains cautiously optimistic about the course of business for the remainder of the year. Already in October, for example, the Company closed on an equipment sale that was long in the making, a transaction that will have an positive impact on the fourth-quarter earnings. Taking into account all of the opportunities and risks of which the Company is aware, UMS expects sales and earnings per share for 2013 to come in at the lower end of its forecast range, which is revenues of EUR 43 million to EUR 45 million and earnings per share of 60 to 65 cents.

All in all, UMS AG intends to maintain its shareholder-friendly dividend policy for fiscal year 2013, provided that the USD/EUR exchange rate does not substantially weaken from its current level. UMS AG paid a dividend of 55 cents per share for fiscal 2012.

The Company expects moderate sales and earnings growth for fiscal 2014.

A PDF copy of the complete report for the third quarter and first nine months of 2013 will be available in German and English on the Company’s website at www.umsag.com starting November 12, 2013.

About UMS AG

UMS International AG is a provider of innovative healthcare delivery concepts in the growth segment of high-tech medicine. UMS pioneered the mobile deployment of high-class medical systems and markets a comprehensive range of full-service solutions for hospitals and specialists. The forward-looking concepts include complete services for the customer, covering everything from system management to the provision of trained application specialists. The UMS Group currently has around 219 employees worldwide and serves over 900 customers.

Contact
Astrid Soltau, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-mail: investor@umsag.com
Borsteler Chaussee 53, 22453 Hamburg

This release was published on openPR.